Five to seven days after the start of the stroke, Tregs infiltrate the brain parenchyma, drive microglial polarization toward the M2 phenotype, and inhibit astrocytic activation by blocking the Amphiregulin (AREG)/Epidermal Growth Factor Receptor (EGFR) pathway [141, 142]. This evidence concerns the gene AREG and stroke disorder.